Jonas Oldgren Selected Research

N(4)-oleylcytosine arabinoside

1/2021	Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale: From the COMBINE AF (A Collaboration between Multiple institutions to Better Investigate Non-vitamin K antagonist oral anticoagulant use in Atrial Fibrillation) Investigators.
1/2021	Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials.
1/2018	The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary.
1/2018	The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
12/2017	Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial.
1/2017	Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study.
1/2017	Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.
1/2016	[Anticoagulants after acute ischemic stroke with atrial fibrillation].
10/2015	Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.
9/2015	[Large studies of NOAC shows good and safe stroke protection].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonas Oldgren Research Topics

Disease

89	Atrial Fibrillation 01/2022 - 02/2008
69	Hemorrhage 11/2022 - 03/2007
64	Stroke (Strokes) 01/2022 - 02/2008
23	Embolism (Embolus) 01/2022 - 09/2009
22	Myocardial Infarction 01/2022 - 10/2004
11	Heart Failure 01/2022 - 01/2016
11	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 02/2004
10	Acute Coronary Syndrome 01/2021 - 03/2007
9	Thrombosis (Thrombus) 01/2022 - 01/2007
9	Ischemic Stroke 12/2020 - 07/2012
6	Inflammation (Inflammations) 01/2022 - 08/2008
6	Neoplasms (Cancer) 01/2018 - 05/2013
5	Chronic Renal Insufficiency 01/2022 - 05/2013
5	ST Elevation Myocardial Infarction 08/2021 - 02/2008
5	Chest Pain (Chest Pains) 02/2010 - 10/2004
4	Cardiovascular Diseases (Cardiovascular Disease) 09/2021 - 01/2018
2	Necrosis 01/2022 - 08/2005
2	Vascular Calcification 11/2021 - 12/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2019
2	Ischemia 12/2020 - 01/2018
2	Fibrosis (Cirrhosis) 12/2020 - 01/2017
2	COVID-19 12/2020 - 11/2020
2	Out-of-Hospital Cardiac Arrest 04/2020 - 01/2019
2	Hypertension (High Blood Pressure) 01/2020 - 09/2010
2	Confusion (Bewilderment) 01/2018 - 01/2018
2	Liver Diseases (Liver Disease) 01/2018 - 01/2018
2	Death (Near-Death Experience) 01/2018 - 02/2012
2	Thromboembolism 03/2016 - 03/2015
2	Pulmonary Embolism 12/2015 - 02/2012
2	Infarction (Infarctions) 08/2008 - 02/2008
1	Atrial Flutter (Flutter, Atrial) 01/2022
1	Dementia (Dementias) 01/2022
1	Peripheral Arterial Disease 09/2021
1	Body Weight (Weight, Body) 01/2021

Drug/Important Bio-Agent (IBA)

48	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 09/2009
46	Dabigatran FDA Link 01/2022 - 09/2009
32	AnticoagulantsIBA 01/2022 - 02/2008
25	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2005
20	Vitamin K FDA Link 01/2022 - 05/2009
20	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2021 - 03/2007
17	Clopidogrel (Plavix)FDA Link 08/2021 - 01/2007
12	apixabanIBA 01/2022 - 12/2013
12	N(4)-oleylcytosine arabinosideIBA 01/2021 - 05/2013
10	Pharmaceutical PreparationsIBA 11/2022 - 11/2009
10	TicagrelorIBA 08/2021 - 10/2017
9	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 04/2012
8	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 04/2012
8	Troponin IIBA 01/2019 - 10/2004
6	Cystatin CIBA 01/2022 - 08/2008
6	TroponinIBA 01/2020 - 02/2004
5	Troponin T (Troponin T1)IBA 01/2022 - 06/2016
5	Growth Differentiation Factor 15IBA 11/2021 - 01/2017
5	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 02/2004
4	CreatinineIBA 01/2022 - 03/2014
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 02/2013
4	fibrin fragment D (D-dimer)IBA 11/2017 - 03/2007
4	AntithrombinsIBA 11/2011 - 02/2004
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2015
3	RivaroxabanIBA 01/2022 - 12/2013
3	Fondaparinux (Arixtra)FDA Link 02/2015 - 02/2008
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 12/2013
2	Trefoil Factor-3IBA 01/2022 - 12/2020
2	N- acetyl- S- (alpha- methyl- 4- (2- methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl esterIBA 12/2021 - 10/2017
2	dapagliflozinIBA 01/2021 - 01/2019
2	omega-Chloroacetophenone (Mace)IBA 01/2018 - 06/2013
2	Thrombin FDA Link 11/2017 - 02/2004
2	edoxabanIBA 01/2017 - 01/2017
2	C-Reactive ProteinIBA 01/2017 - 12/2015
2	trans-crotonin (CTN)IBA 06/2016 - 05/2016
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 09/2010 - 02/2008
2	Dalteparin (Dalteparin Sodium)FDA Link 09/2008 - 03/2008
2	ximelagatran (Exanta)IBA 02/2008 - 03/2007
2	MyoglobinIBA 08/2005 - 10/2004
2	MB Form Creatine KinaseIBA 08/2005 - 10/2004
1	Factor XIa (Coagulation Factor XIa)IBA 01/2022
1	CathepsinsIBA 01/2022
1	Factor Xa (Coagulation Factor Xa)IBA 01/2022
1	CalciumIBA 01/2022
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2022
1	Dronedarone FDA Link 01/2022
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2022
1	Fibroblast Growth Factor-23IBA 01/2022
1	Factor Xa InhibitorsIBA 01/2022
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2022
1	Anti-Arrhythmia AgentsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	darapladibIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021

Therapy/Procedure

63	Therapeutics 11/2022 - 02/2008
24	Percutaneous Coronary Intervention 01/2022 - 01/2007
9	Electric Countershock (Cardioversion) 01/2018 - 01/2011
6	Stents 01/2021 - 01/2007
3	Drug Therapy (Chemotherapy) 11/2022 - 01/2018
2	Vascular Surgical Procedures 11/2022 - 10/2022
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2019 - 11/2009
2	Secondary Prevention 09/2017 - 12/2013
2	Thrombolytic Therapy 09/2010 - 02/2008
1	Contraindications 01/2021